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Abstract 
Introduction: Those responsible for planning and commissioning health services require 
a method of assessing the benefits and costs of interventions.  Quality adjusted life years, 
based on health-related quality of life (HRQoL) tariffs, can be used as part of this 
commissioning process.  The purpose of this study was to generate nationally 
representative HRQoL tariff estimates for demographic characteristics, lifestyle factors 
and chronic conditions using data from the Health Survey for England. 
 
Methods:  The EQ-5D was used to elicit mean health-related HRQoL tariffs for the 
participants. Mean HRQoL tariffs for socio-demographic characteristics and various 
health conditions were calculated. Regression modelling was used to estimate the 
independent impact of each socio-demographic factor and health condition on HRQoL 
tariffs. 
 
Results: Minor psychiatric morbidity symptoms were strongly associated with 
substantially reduced HRQoL. Of the chronic conditions studied, doctor diagnosed 
arthritis and chronic lung disease had the greatest impact on HRQoL among the over 65s. 
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Discussion: The estimates calculated provide nationally representative baseline data for 
England.  These estimates can be used for modelling the impact of various interventions 
on health-related quality of life. 
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Introduction 
 The National Health Service (NHS) has a responsibility to monitor the health of 
the UK population and to commission services and interventions that will improve health.  
The Department of Health and other Government departments have a similar statutory 
responsibility to evaluate the impact of policy interventions on health and other outcomes 
[1].  In the face of finite resources, it is useful to know which interventions yield the 
greatest benefit.  One way of comparing across diverse interventions aimed at tackling 
different diseases and conditions is to measure their impact on length of life and in 
addition health-related quality of life (HRQoL).  QoL measures incorporate the 
perspective of the user.  They can also be used as an input to calculating Quality Adjusted 
Life Years (QALYs) for health economic evaluation [2].  
 The European Qualify of Life – 5 Domains (EQ-5D) incorporates physical, social 
and mental aspects of HRQoL [3].  It was developed by the EUROQOL group and has 
been used extensively in Europe, the US and worldwide [4-9].  Disease-specific HRQoL 
measures help evaluate and improve services for specific diseases but they cannot be used 
to compare across different health conditions.  In contrast, HRQoL as assessed by generic 
measures such as the EQ-5D has been compared across a range of long-term conditions 
for large samples representative of the US population [6-7].   
 One challenge in the use of self-ratings of health is that they can be difficult to 
compare across individuals as they can arise out of differential expectations as well as out 
of true differences in health.  In particular, expectations for health can change with age: 
Studies using anchoring vignettes suggest that younger people rate severity of impairment 
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as greater for a given scenario compared with older people [10].   Studies therefore need 
to consider age as a potential moderator of the disease-HRQoL relationship. 
The aims of the current study were to generate HRQoL estimates for common 
long-term conditions and lifestyle factors for a representative sample of adults in 
England, and to investigate associations with a number of socio-demographic factors 
before and after appropriate adjustment. 
 
Methods 
Data source:  The Health Survey for England (HSE) is an annual cross-sectional survey 
of a new random sample, representative of the non-institutionalised population in 
England.  Each year the HSE focuses on different conditions and/or different population 
subgroups in addition to including a core set of questions.  In years 2003 through to 2006, 
the EQ-5D was included in the HSE [11].  For the core sample, the HSE uses a multi-
stage sampling procedure such that primary sampling units (postcode sectors, stratified 
by proportion of households headed by someone in a manual occupation) are first 
selected.  At the next stage, a random sample of households is selected, and finally up to 
ten adults are selected within each household.  In 2003 through 2006, all core participants 
were asked to complete the EQ-5D.  In 2005, an additional nationally-representative 
boost sample of free-living participants aged 65 and over also completed the EQ-5D [12].  
Trained interviewers collected information face-to-face and measured weight and height.  
A nurse then visited to ask further questions, take more measurements and collect 
biological samples.  Ethical approval was obtained from an appropriate Research Ethics 
Committee prior to each survey. 
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EQ-5D:  The EQ-5D has five domains capturing mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression.  Each domain has three possible levels 
indicating no problems, moderate problems or severe problems.  This results in a series of 
243 possible health states, with (1 1 1 1 1) representing optimal health by convention [3].  
Participant’s responses on these five domains are converted to the EQ-5D tariff using a 
time trade-off (TTO) method.  QoL tariffs are sometimes determined through the direct 
application of preference elicitation procedures (via TTO, standard gamble, or visual 
analogue scales) to the participants of a specific study.  Although this approach has the 
advantage that a health state can be evaluated directly, increasingly studies of specific 
interventions use the alternative approach of first translating the participant's health state 
into the dimensions captured by a specific health status questionnaire such as the EQ-5D 
and then assigning a QoL tariff corresponding to that health state based on a previous 
valuation study of that survey instrument. This approach is less expensive and can be 
more reliable because the previously calibrated weights are often based on a larger and 
more representative sample of the population than would be possible in the study of a 
specific intervention.  The tariffs used in the current study have been derived for the UK 
in a separate sample in a study undertaken in the 1990s.  Details are given elsewhere [13] 
but briefly, respondents were asked how long they were willing to spend in the optimal 
health state for it to be equivalent to 10 years in the particular health state in question.  
Shorter periods of time indicate a poorer health state.  Responses were then transformed 
to create the EQ-5D tariff which ranges from 1 (optimal health) to -1 (worse than dead), 
with 0 being equivalent to dead.  The algorithm based on this external sample was 
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applied to responses from HSE participants to create the EQ-5D tariff for each 
participant. 
 
Long-term conditions and lifestyle factors:  The following items were included in all core 
and boost samples.  Symptoms indicating minor psychiatric morbidity were captured by 
the 12-item General Health Questionnaire (GHQ) [14].  Participants were coded as 
having 0, 1-3 or 4+ symptoms, where 4+ indicates probable psychological disturbance.  
Measured height and weight were used to calculate body mass index and code 
participants to Obese (BMI>= 30kg/m
2
), Overweight (30kg/m
2
>BMI>= 25kg/m
2
) or 
Normal/underweight categories (BMI<25kg/ m
2
).  Smoking status was coded as Current, 
Ex- or Never regular cigarette smoking. 
Doctor-diagnosed conditions (hypertension, angina, heart attack, diabetes and stroke) 
were reported by participants in the core samples in 2003 and 2006 and by those aged 65 
and over (core and boost) in 2005 in response to direct questions but were not asked in 
HSE 2004.  Self-reports have been validated against disease/event registers [15].  A 
participant was coded as being hypertensive if a doctor had diagnosed hypertension or 
their measured blood pressure was systolic >=140mmHg, diastolic >=90mmHg, or they 
were taking medication to lower their blood pressure.  The presence or absence of an 
extended list of long-term conditions was asked for participants aged 65 and over (core 
and boost) in the HSE 2005 only.  This included frequency of bladder problems (coded as 
At least once a week or Less frequently/not at all), whether the participant had had a fall 
in the last 12 months, plus a list of additional self-reported doctor-diagnosed conditions: 
chronic lung disease, asthma, arthritis and osteoporosis.   
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Socio-demographic characteristics:  Sex, age, ethnicity, economic activity, occupation 
and educational attainment were reported by participants.  For these analyses, ethnic 
group was coded as White, Mixed, Black/Black British, Asian/Asian British and Other 
ethnic group according to the 2001 Census five category classification.  Economic 
activity was coded as In paid employment, Unemployed, Retired, Other economically 
inactive.  The latter group was heterogeneous and included people who were in full-time 
education, home-makers and those unable to work because of long-term sickness or 
disability.  Socioeconomic position based on occupation was coded according to the 
National Statistics Socioeconomic Classification (NSSEC) in five categories of 
occupation (Managerial/professional occupations, Intermediate occupations, Small 
employers and own account workers, Lower supervisory and technical occupations, 
Semi-routine occupations) plus a separate category for those who could not be classified.  
Highest level qualification was coded as National Vocational Qualification (NVQ) 
NVQ4/NVQ5/degree level, Higher education below degree/NVQ3/A level equivalent, 
NVQ2/O level equivalent/NVQ1/CSE equivalent, No qualification. 
 
Statistical analysis:  Means were estimated using sampling weights to correct for non-
response based on known probability of sampling and allowing for the complex survey 
design.  Unadjusted mean EQ-5D tariffs are presented initially.  Tobit regression was 
then used to estimate EQ-5D tariffs adjusted for socio-demographic factors (sex, age, 
ethnicity, economic activity, socioeconomic position and educational attainment) in three 
models.  The first modelled the independent contribution of lifestyle factors (body mass 
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index category and smoking status) and minor psychiatric morbidity to HRQoL.  The 
second modelled the independent contribution of long-term conditions (hypertension, 
angina, heart attack, stroke and diabetes).  The third modelled the contribution of an 
extended set of long-term conditions (bladder problems, lung disease, asthma, arthritis, 
osteoporosis and falls) in a subset of boost participants.  Tobit regression allows the 
specification of floor and ceiling effects in the outcome of interest and was used here 
because there is a ceiling of 1 on the EQ-5D tariff [16].  It assumes there is an underlying 
latent HRQoL and treats those who score 1 as being censored at that point. 
 
Participants:  Modules included in the HSE change from year to year.  Table 1 
summarises the participant samples included for each of the above models.  Items 
capturing lifestyle were included for the core sample in 2003-2006.  The core sample is 
representative of the general population in England.  Items capturing long-term 
conditions were included in the core samples for 2003, 2005 and 2006 and also for the 
older person’s boost in 2005.  To ensure representativeness when the boost sample was 
included, analyses of long-term conditions were stratified by age.  Participants who were 
excluded because of missing HRQoL data (3,853 out of 45,161 core participants, yielding 
41,308 for analysis) were more likely to be male (9% of men had missing data versus 8% 
for women), older (13% of the over 65s versus 7% for younger participants), retired (12% 
versus 6% for those in employment), in a lower socioeconomic group (11% in NSSEC5 
versus 6% in NSSEC1), of lower educational attainment (15% of those with no 
qualifications versus 5% of those with the highest qualifications) and non-white (20% 
versus 7% of white participants). 
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Results 
 The unadjusted mean EQ-5D tariff was lower for women, older people, retired 
and economically inactive people, those in lower and routine socioeconomic classes and 
those with lower educational attainment (Table 2).  Only age and socioeconomic factors 
were independently associated with EQ-5D tariff in the adjusted analysis. 
In unadjusted analyses and adjusting for socio-demographic characteristics and 
other lifestyle factors, the mean EQ-5D tariff was lower for smokers and ex-smokers and 
those with BMI of 25kg/m
2
 or more (Table 3).  Those with one or more, and especially 
those with four or more, symptoms of minor psychiatric morbidity had substantially 
reduced EQ-5D tariffs.  The reduction in EQ-5D tariff with minor psychiatric morbidity 
symptoms and overweight/obesity were a little larger for the over 65s compared with the 
younger subset.  The association between EQ-5D tariff and smoking was greater for 
younger participants, possibly because of selective survival of older smokers.  Unadjusted 
mean EQ-5D tariffs for health conditions (hypertension, angina, heart attack, stroke and 
diabetes) by socio-demographic factors are summarised in Appendix 1.  These show how 
each condition impacts on quality of life differentially by age and especially by 
socioeconomic factors, indicating that the quality of life among those in more socially 
disadvantaged circumstances is lower for a given condition than those who are more 
advantaged. 
Adjusted mean EQ-5D was lower for participants with angina, stroke or diabetes 
(Table 4).  This finding held for those aged less than 65 and for the over 65s but the 
reduction in HRQoL associated with each long-term condition was greater in the younger 
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sample.  Hypertension was associated with a reduction in HRQoL for those aged less than 
65 but not for the over 65s. 
 Of the long-term conditions, only hypertension, diabetes and heart attack did not 
have an independent statistically significant association with mean EQ-5D tariff (Table 5) 
adjusted for socio-demographic characteristics and other long-term conditions.  Four 
conditions were associated with a reduction in mean EQ-5D of over 0.1 points, namely 
arthritis (reduction of 0.239 points (standard error 0.026)), chronic lung disease (0.168 
(0.036)), stroke (0.144 (0.047)) and bladder problems (0.128 (0.026)). 
 
Discussion  
Strengths and limitations 
This study was based on recent data from over 40,000 adults in a sample 
representative of the population of England.  Multiple lifestyle factors and commonly 
occurring long-term conditions were considered as potential contributors to HRQoL.  
Before discussing the findings, some limitations should be noted.  Although the 
assumption is that disease precedes declines in HRQoL, this cannot be tested in a cross-
sectional survey.  A range of lifestyle factors and long-term conditions were considered 
but the HSE lacks details on the severity and management of most of these.  Most 
crucially, only one measure of HRQoL, namely the EQ-5D, was considered here.  This 
measure has been extensively used in international studies, nevertheless it is possible that 
alternative measures of HRQoL may accentuate different health conditions as being 
important [17]. 
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The TTO method trades length of life for HRQoL : Respondents in the TTO 
sample were asked what proportion of their remaining life they would forfeit in exchange 
for removal of the given health problem.  This study used a UK-based TTO survey to 
elicit social preference weights in the algorithm which creates HRQoL tariffs from 
responses to items in the EQ-5D.  Whilst this study has the advantage of being able to use 
domestic weights, the appropriateness of using population preferences rather than 
preferences reported by individuals with the condition has been questioned [18].  In 
particular, the tariffs reported by people with and without the condition of interest vary 
substantially [18].  The TTO method itself has been criticised on several levels, including 
its assumption that quality can be traded for quantity of life and that true preferences are 
revealed in a hypothetical scenario [19].  Nevertheless, the method is the most widely 
used approach to adjusting length of life for quality when deriving QALYs [19].  
 Tobit regression was used to allow for the distribution of the EQ-5D, which has a 
spike of observations at the ceiling of 1.  This method was selected because it was 
available in standard software which allows for the complex survey design although 
recent comparisons of alternative methods for analysing the EQ-5D suggest that two-part 
models may be preferable for accurately representing the distributions [20, 21]. 
 
Main findings 
Symptoms of minor psychiatric morbidity were the closest correlates of HRQoL, 
as assessed by the EQ-5D.  Previous UK studies suggest that minor psychiatric morbidity 
has a prevalence around 16% [22] and this study found 13% of participants had four or 
more symptoms on the GHQ12.  That minor psychiatric morbidity is so prevalent 
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indicates that there is great scope for improving HRQoL through interventions to improve 
psychological well-being.  This accords with other work showing depression and other 
common mental disorders to be major contributors to HRQoL [7, 23-25].  However, 
given that the two measures, namely the GHQ12 and the EQ-5D, are self-reported 
concurrently it is worth re-stating that this study cannot claim to identify causal 
relationships.  Furthermore, the anxiety/depression domain of the EQ-5D aims to directly 
capture symptoms of common mental disorder so the close association between the two 
measures may simply be explained by the fact that they are different items capturing the 
same underlying construct.  However, closer analysis suggests this is not the case.  
Reporting symptoms of common mental disorder was strongly associated with more 
severe limitation on the mobility, self-care, usual activities and pain/discomfort domains 
(p<0.001 based on chi-squared test; data available from authors). 
Of the long-term conditions considered, arthritis and chronic lung disease had the 
greatest independent impact on HRQoL.  Stroke, bladder problems, osteoporosis, falls, 
angina and asthma also impacted on HRQoL, independently of all other long-term 
conditions and of socio-demographic characteristics.  This concurs with other research 
showing that arthritis/joint pain and stroke are major determinants of EQ-5D scores.[6, 
25-30].  It is important to note that the regression estimates presented portray the 
independent contribution of each condition to HRQoL so that a person who had 
experienced a stroke and bladder problems would be expected to have an EQ-5D of 0.272 
points lower (based on estimates of -0.128 for bladder problems and -0.144 for stroke 
from Table 5) than one who had experienced neither of those conditions, all other factors 
being equal. 
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 The impact of some of the long-term conditions on HRQoL was greater for 
participants aged 65 and under compared with older participants.  One explanation is that 
younger participants have higher expectations for their health so that, for a given level of 
impairment they select a lower health state [10].  Alternatively, informal and statutory 
support may be more readily available at older ages, or the daily tasks required of 
younger people may highlight functional difficulties more readily.  Exploration of the 
explanations are beyond the scope of this study but the findings highlight that initiatives 
aimed primarily at older people may miss opportunities to have greater impact on 
HRQoL. 
 
Application of findings 
There are a number of ways in which these tariffs could be used in health policy-
making or service improvement, both of which may wish to compare the outcomes and 
utilities of alternative treatment strategies.  Health policy-makers are required to produce 
impact assessments of costly new policies [31].  Increasingly these use QALY valuations, 
as do NICE technology assessments [32].  Commissioners and service providers may also 
wish to compare the outcomes of treatment [33].   While this may involve adjustment for 
sociodemographic characteristics, there is increasing interest in addressing equity and 
distributional issues in such comparisons.  This study demonstrates that, after adjustment 
for other sociodemographic factors, HRQoL is strongly associated with economic status, 
social class and education. 
 The study demonstrates that minor psychiatric morbidity at all ages and arthritis 
among the over 65s are key contributors to suboptimalHRQoL.  These estimates of 
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HRQoL for various long-term conditions and lifestyle factors may be useful for 
modelling and forecasting.  In combination with prevalence or incidence data, the 
estimates could be used to help prioritise health and social care interventions.  
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Table 1: Data availability by survey year 
 
Survey Year Sample type Core participants 
with HRQoL and 
lifestyle data 
Participants with HRQoL and long-term 
conditions data 
Participants with 
HRQoL and 
extended long-term 
conditions data 
   <65 years 65 and over 65 and over 
2003 Core 13469 10943 2810 0 
2004 Core 6006 0 0 0 
2005 Core 8288 7134 1381 1381 
 Older boost 0 0 2351 2351 
2006 Core 12632 10072 2854 0 
a
Maximum total for 
analysis 
 41308 28149 9396 3732 
a
Exact number available for analysis depends on exposure of interest 
 19 
Table 2. Mean EQ-5D tariff by socio-demographic characteristics (based on data from all participants from the Health Survey for 
England 2003-2006 core samples ) 
 
 
Number of 
participants 
Mean TTO 
derived 
HRQoL tariff 
using EQ-5D 
95% 
Confidence 
Interval 
a
Adjusted 
regression 
coefficient (s.e.) 
p-value for 
regression 
coefficient 
All participants 41308 0.864 0.859, 0.870   
       
Year 
2003 13753 0.869 0.859, 0.870 Reference  
2004  6114 0.863 0.865, 0.873 -0.017 (0.009) 0.05 
2005 8515 0.872 0.866, 0.878 -0.004 (0.008) 0.6 
2006 12926 0.868 0.864, 0.872 0.004 (0.006) 0.6 
       
Sex 
Female 22801 0.853 0.847, 0.859 Reference  
Male 18507 0.876 0.869, 0.883 0.005 (0.009) 0.6 
Age 
16-24 4549 0.940 0.932, 0.948 Reference  
25-34 6479 0.927 0.920, 0.940 -0.102 (0.021) <0.001 
35-44 8369 0.899 0.891, 0.908 -0.185 (0.021) <0.001 
45-54 6810 0.852 0.838, 0.865 -0.278 (0.023) <0.001 
55-64 6704 0.811 0.798, 0.824 -0.280 (0.023) <0.001 
65-74 4741 0.792 0.777, 0.807 -0.246 (0.027) <0.001 
75+ 3656 0.725 0.708, 0.741 -0.333 (0.028) <0.001 
Ethnic group 
White 38250 0.863 0.857, 0.868 Reference  
Mixed 300 0.913 0.895, 0.932 -0.024 (0.052) 0.6 
Asian or Asian British 1495 0.875 0.860, 0.889 -0.021 (0.029) 0.5 
Black or Black British 865 0.901 0.880, 0.921 0.034 (0.036) 0.3 
Chinese or other ethnic 
group 
364 0.854 0.803, 0.904 
0.018 (0.051) 
0.7 
Economic 
Status 
In employment 23317 0.922 0.919, 0.927 Reference  
ILO unemployed 1836 0.923 0.911, 0.936 -0.064 (0.025) 0.01 
Retired 9068 0.762 0.751, 0.773 -0.183 (0.019) <0.001 
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Other economically inactive 7024 0.759 0.742, 0.776 -0.279 (0.016) <0.001 
Social Class 
(NS-SEC) 
Managerial and professional  16895 0.904 0.899, 0.910 Reference  
Intermediate occupations 3587 0.868 0.855, 0.881 -0.039 (0.016) 0.02 
Small employers and own 
account workers 
4472 0.864 0.850, 0.878 
-0.041 (0.017) 
0.02 
Lower supervisory and 
technical occupations 
4677 0.856 0.842, 0.871 
-0.030 (0.016) 
0.06 
Semi-routine occupations 10806 0.807 0.795, 0.819 -0.100 (0.013) <0.001 
Highest 
Educational 
Qualification 
 
NVQ4/NVQ5/Degree 7594 0.925 0.918, 0.931 Reference  
Higher ed/NVQ3/A Level  9953 0.895 0.888, 0.903 -0.057 (0.014) <0.001 
NVQ2/NVQ1 11952 0.887 0.880, 0.894 -0.039 (0.015) 0.007 
No qualification 10654 0.767 0.755, 0.778 -0.118 (0.016) <0.001 
s.e. standard error 
a
Adjusted for all other lifestyle factors and sex, age group, ethnicity, educational attainment, economic activity status and social class 
of household reference person
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Table 3. Health-related quality of life weights for lifestyle factors and minor psychiatric morbidity: core participants 
 
 
Number of 
participants 
Mean TTO 
derived HRQoL 
tariff using EQ-
5D 
95% Confidence 
Interval 
a
Adjusted 
regression 
coefficient (s.e.) 
p-value for 
regression 
coefficient 
Age<65 
Cigarette 
Smoking Status 
Never regular smoker  20973 0.888 0.882, 0.893 Reference   
Ex-regular smoker 10539 0.834 0.825, 0.843 -0.022 (0.012) 0.08 
Current smoker 9735 0.846 0.834, 0.857 -0.071 (0.012) <0.001 
 
GHQ12 Score  
0 25994 0.925 0.921, 0.929 Reference  
1-3 9254 0.828 0.818, 0.838 -0.218 (0.012) <0.001 
4+ 5445 0.645 0.625, 0.665 -0.456 (0.014) <0.001 
 
Body mass 
index 
Under 25 13934 0.906 0.900, 0.912 Reference  
25-30 13934 0.875 0.868, 0.882 -0.032 (0.011) 0.004 
Over 30 8742 0.828 0.817, 0.839 -0.084 (0.014) <0.001 
Age 65 and over 
Cigarette 
Smoking Status 
Never regular smoker  20973 0.888 0.882, 0.893 Reference   
Ex-regular smoker 10539 0.834 0.825, 0.843 -0.014 (0.017) 0.4 
Current smoker 9735 0.846 0.834, 0.857 -0.029 (0.025) 0.2 
 
GHQ12 Score  
0 25994 0.925 0.921, 0.929 Reference  
1-3 9254 0.828 0.818, 0.838 -0.240 (0.018) <0.001 
4+ 5445 0.645 0.625, 0.665 -0.501 (0.029) <0.001 
 
Body mass 
index 
Under 25 13934 0.906 0.900, 0.912 Reference  
25-30 13934 0.875 0.868, 0.882 -0.023 (0.019) 0.2 
Over 30 8742 0.828 0.817, 0.839 -0.100 (0.021) <0.001 
s.e. standard error 
a
Adjusted for sex, age group, ethnicity, educational attainment, economic activity status, social class of 
household reference person, smoking, minor psychiatric morbidity and body mass index 
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Table 4. Health-related quality of life tariffs for long-term conditions by age: core and boost participants 
 
 
Number of 
participants 
Mean TTO 
derived HRQoL 
tariff using EQ-
5D 
95% Confidence 
Interval 
a
Adjusted 
regression 
coefficient (s.e.) 
p-value for 
regression 
coefficient 
Age <65 
Hypertension 
Not hypertensive 2133 0.903 0.895, 0.906 Reference   
Hypertensive 15208 0.819 0.807, 0.831 -0.046 (0.011) <0.001 
 
Doctor diagnosed 
angina 
No 27795 0.895 0.892, 0.897 Reference  
Yes 352 0.629 0.591, 0.666 -0.212 (0.031) <0.001 
 
Doctor diagnosed 
heart attack 
No 27894 0.893 0.891, 0.896 Reference  
Yes 255 0.652 0.612, 0.693 -0.062 (0.036) 0.09 
 
Doctor diagnosed 
stroke 
No 27958 0.893 0.891, 0.896 Reference  
Yes 191 0.625 0.574, 0.675 -0.159 (0.040) <0.001 
 
Doctor diagnosed 
diabetes 
No 27564 0.895 0.892, 0.897 Reference  
Yes 584 0.741 0.713, 0.768 -0.111 (0.023) <0.001 
Age 65 and over 
Hypertension Not hypertensive 3384 0.783 0.773, 0.794 Reference   
 Hypertensive 3015 0.771 0.760, 0.781 -0.003 (0.013) 0.8 
 
Doctor diagnosed 
angina 
No 6863 0.786 0.778, 0.794 Reference  
Yes 1139 0.661 0.639, 0.683 -0.126 (0.020) <0.001 
 
Doctor diagnosed 
heart attack 
No 7234 0.780 0.772, 0.788 Reference  
Yes 766 0.661 0.634, 0.689 -0.047 (0.023) 0.04 
 
Doctor diagnosed No 7408 0.779 0.771, 0.787 Reference  
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Number of 
participants 
Mean TTO 
derived HRQoL 
tariff using EQ-
5D 
95% Confidence 
Interval 
a
Adjusted 
regression 
coefficient (s.e.) 
p-value for 
regression 
coefficient 
stroke Yes 593 0.632 0.602, 0.663 -0.132 (0.024) <0.001 
 
Doctor diagnosed 
diabetes 
No 7173 0.774 0.765, 0.782 Reference  
Yes 830 0.721 0.697, 0.745 -0.057 (0.021) 0.008 
s.e. standard error 
a
Adjusted for and sex, age group, ethnicity, educational attainment, economic activity status, social class of household reference 
person, hypertension and doctor diagnosed conditions (angina, heart attack, stroke and diabetes) 
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Table 5. Health-related quality of life tariffs for extended list of long-term conditions: participants over 65 in HSE 2005 
 
 
Number of 
participants 
Mean TTO 
derived HRQoL 
tariff using EQ-
5D 
95% Confidence 
Interval 
a
Adjusted 
regression 
coefficient (s.e.) 
p-value for 
regression 
coefficient 
Bladder problems 
No 2941 0.798 0.782, 0.814 Reference   
Yes 675 0.639 0.604, 0.674 -0.128 (0.026) <0.001 
 
Doctor diagnosed 
chronic lung disease 
No 3446 0.772 0.756, 0.789 Reference  
Yes 286 0.667 0.610, 0.723 -0.168 (0.036) <0.001 
 
Doctor diagnosed 
asthma 
No 3315 0.775 0.759, 0.791 Reference  
Yes 417 0.676 0.624, 0.727 -0.090 (0.036) 0.01 
 
Doctor diagnosed 
arthritis 
No 2252 0.842 0.825, 0.859 Reference  
Yes 1480 0.654 0.629, 0.679 -0.239 (0.026) <0.001 
 
Doctor diagnosed 
osteoporosis 
No 3450 0.777 0.892, 0.897 Reference  
Yes 282 0.613 0.558, 0.667 -0.090 (0.042) 0.03 
 
Fall in last 12 
months 
No 2787 0.791 0.776, 0.808 Reference   
Yes 945 0.679 0.646, 0.713 -0.095 (0.028) 0.001 
 
Hypertension 
Not hypertensive 1334 0.784 0.760, 0.809   
Hypertensive 1145 0.771 0.745, 0.796 -0.037 (0.024) 0.13 
 
Doctor diagnosed 
angina 
No 3202 0.788 0.772, 0.805 Reference  
Yes 528 0.627 0.584, 0.670 -0.086 (0.039) 0.03 
 
Doctor diagnosed No 3363 0.777 0.761, 0.794 Reference  
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Number of 
participants 
Mean TTO 
derived HRQoL 
tariff using EQ-
5D 
95% Confidence 
Interval 
a
Adjusted 
regression 
coefficient (s.e.) 
p-value for 
regression 
coefficient 
heart attack Yes 369 0.659 0.612, 0.706 -0.070 (0.040) 0.08 
       
Doctor diagnosed 
stroke 
No 3468 0.775 0.759, 0.791 Reference  
Yes 262 0.617 0.549, 0.685 -0.144 (0.047) 0.003 
 
Doctor diagnosed 
diabetes 
No 3334 0.769 0.752, 0.785 Reference  
Yes 398 0.729 0.679, 0.778 -0.051 (0.042) 0.2 
s.e. standard error 
a
Adjusted for sex, age group, ethnicity, educational attainment, economic activity status, social class of household reference person, 
bladder problems, falls, hypertension and doctor diagnosed conditions (angina, heart attack, stroke, diabetes, lung disease, asthma, 
arthritis and osteoporosis) 
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Appendix 1. Health-related quality of life tariffs for long-term conditions by sociodemographic characteristics: core and boost 
participants 
 
 Hypertension 
Doctor 
diagnosed 
angina 
Doctor 
diagnosed heart 
attack 
Doctor 
diagnosed stroke 
Doctor 
diagnosed 
diabetes 
 
Sex 
Male 
0.819 
(0.809,0.829) 
0.684 
(0.666,0.703) 
0.696 
(0.676,0.715)
 
 
0.633 
(0.611,0.656)
 
 
0.758 
(0.741,0.775)
 
 
Female 
0.763 
(0.754,0.773) 
0.626 
(0.608,0.664) 
0.614 
(0.593,0.635) 
0.635 
(0.614,0.657) 
0.690 
(0.671,0.709) 
       
Age 
<50 
0.849 
(0.831,0.867) 
a
 
0.654 
(0.567,0.740)
 a 
 
0.677 
(0.634,0.720)
 a 
 
0.780 
(0.747,0.812)
 
 
<65 
0.803 
(0.789,0.817) 
0.631 
(0.607,0.655)
a
 
0.652 
(0.628,0.676) 
0.599 
(0.572,0.637) 
0.716 
(0.695,0.737) 
<75 
0.798 
(0.786,0.809) 
0.682 
(0.660,0.704) 
0.711 
(0.684,0.738) 
0.661 
(0.634,0.688) 
0.738 
(0.720,0.756) 
75+ 
0.747 
(0.735,0.759) 
0.657 
(0.639,0.676) 
0.639 
(0.617,0.662) 
0.620 
(0.600,0.657) 
0.685 
(0.664,0.707) 
       
Economic Status 
In employment 
0.898 
(0.889,0.906) 
0.817 
(0.805,0.829) 
0.847 
(0.836,0.857) 
0.791 
(0.750,0.833)
a
 
0.880 
(0.870,0.889)
a
 
ILO unemployed 
a
 
a
 
a
 
a
 
a
 
Retired 
0.773 
(0.764,0.782) 
0.667 
(0.652,0.683) 
0.669 
(0.650,0.688) 
0.633 
(0.614,0.652) 
0.708 
(0.692,0.725) 
Other economically 
inactive 
0.640 
(0.619,0.661) 
0.505 
(0.477,0.533) 
0.519 
(0.491,0.547) 
0.531 
(0.505,0.557) 
0.515 
(0.486,0.543) 
       
Social Class  
(NS-SEC) 
Managerial and 
professional  
0.841 
(0.831,0.850) 
0.722 
(0.701,0.742) 
0.715 
(0.696,0.735) 
0.695 
(0.673,0.716) 
0.787 
(0.770,0.803) 
Intermediate 
occupations 
0.790 
(0.774,0.806) 
0.683 
(0.667,0.698) 
0.670 
(0.635,0.705) 
0.594 
(0.552,0.636)
a
 
0.708 
(0.687,0.729)
a
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 Hypertension 
Doctor 
diagnosed 
angina 
Doctor 
diagnosed heart 
attack 
Doctor 
diagnosed stroke 
Doctor 
diagnosed 
diabetes 
Small employers and 
own account workers 
0.816 
(0.802,0.830) 
0.653 
(0.638,0.668) 
0.641 
(0.629,0.652) 
0.637 
(0.589,0.685)
a
 
0.753 
(0.727,0.778)
a
 
Lower supervisory 
and technical 
occupations 
0.763 
(0.745,0.781) 
0.631 
(0.608,0.654) 
0.643 
(0.620,0.666) 
0.615 
(0.593,0.636) 
0.706 
(0.681,0.731) 
Semi-routine 
occupations 
0.735 
(0.720,0.749) 
0.620 
(0.599,0.641) 
0.649 
(0.624,0.674) 
0.612 
(0.586,0.638) 
0.681 
(0.657,0.706) 
       
Highest 
Educational 
Qualification 
 
NVQ4/NVQ5/Degree 
0.879 
(0.866,0.892) 
0.755 
(0.744,0.766) 
0.734 
(0.709,0.760) 
0.740 
(0.705,0.776) 
0.835 
(0.819,0.851) 
Higher ed/NVQ3/A 
Level  
0.839 
(0.826,0.857) 
0.736 
(0.711,0.761) 
0.744 
(0.722,0.766) 
0.724 
(0.698,0.749)
a
 
0.777 
(0.755,0.798) 
NVQ2/NVQ1 
0.806 
(0.792,0.820) 
0.674 
(0.656,0.692) 
0.706 
(0.687,0.726) 
0.637 
(0.619,0.655) 
0.736 
(0.711,0.761) 
No qualification 
0.743 
(0.732,0.754) 
0.627 
(0.609,0.646) 
0.632 
(0.609,0.654) 
0.601 
(0.578,0.623) 
0.682 
(0.664,0.701) 
a
estimates based on fewer than 100 participants 
